The Wharton School introduces new undergraduate concentration and MBA major in artificial intelligence for business
The degree is designed to address the world’s growing demand for AI-related skills and expertise, and ‘represents a bold step forward in our mission to prepare the next generation to responsibly lead in an AI-driven world,’ says Wharton dean Erika James. The curriculum includes courses on applied machine learning, data science, neuroscience, data engineering, statistics, and ethics.
2 min. read
The Wharton School of the University of Pennsylvania has announced a new undergraduate concentration and MBA major in artificial intelligence for business. Designed to address the world’s growing demand for AI-related skills and expertise, artificial intelligence for business will equip students with a technical understanding of how AI systems can be used to solve business problems while also tackling the ethical, economic, legal, and societal issues AI raises.
“It is no longer a question of if, but how artificial intelligence will fundamentally alter every aspect of business and society, and business schools have a crucial role to play in ensuring that AI adoption leads to positive outcomes,” says Erika James, dean of the Wharton School. “At Wharton, we are simultaneously focused on harnessing AI’s transformative potential while also understanding and addressing its risks. Artificial Intelligence for Business represents a bold step forward in our mission to prepare the next generation to responsibly lead in an AI-driven world.”
The Artificial Intelligence for Business curriculum will include courses on applied machine learning, data science, neuroscience, data engineering, statistics, and the required ethics course, Big Data, Big Responsibilities: Toward Accountable Artificial Intelligence, among others. This course is led by Professor Kevin Werbach, director of the newly established Accountable AI Lab, which is dedicated to advancing the responsible development and governance of AI technologies.
With support from the Wharton AI & Analytics Initiative, courses will be directly informed by Wharton faculty research, giving students access to academically rigorous and practically relevant knowledge in real-time. The Wharton AI & Analytics Initiative will also provide resources for faculty to augment, adapt, and reimagine how they incorporate AI into classroom instruction and course materials.
“We are at a critical turning point where practical AI knowledge is urgently needed,” said Eric Bradlow, Vice Dean of AI & Analytics at Wharton. “Companies are struggling to recruit talent with the necessary AI skills, students are eager to deepen their understanding of the subject and gain hands-on experience and our faculty’s expertise on the adoption and human impact of AI is unmatched. Wharton is uniquely positioned to lead as we collectively confront the myriad of challenges and opportunities AI poses.”
When the Schuylkill swallowed the city: Lessons from Hurricane Ida’s historic flood
New Penn research shows that Hurricane Ida wasn’t a once-in-a-century anomaly but a preview of how climate change, urbanization, and aging infrastructure are rewriting flood risk.
The Fed explained: What it does and why it matters
Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy
How population changes are impacting primary education worldwide
Research from Penn sociologist Emily Hannum and colleagues reveals regional trends in whether school-age populations are increasing, plateauing, or decreasing—and shows how different countries are responding.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
